Skip To Main Content

Researching Cancer Immunity Targets

We are actively exploring the potential of disrupting the immunosuppressive processes that promote tumor growth and bolstering the immune system's power to fight cancer.

CD20 CD3

Explore CD20 CD3

See how targeting CD20 and CD3 can harness the immune system against cancer.


Explore CEA CD3

Learn about the potential of simultaneous binding CEA on tumor cells and CD3 on T cells.


Explore PD-L1

Investigate the PD-L1 pathway and cancer immune evasion.


Explore TIGIT

Learn about targeting the novel TIGIT immune checkpoint and anti-tumor immunity.